Glucagon‐like peptide‐1 analog improves neuronal and behavioral impairment and promotes neuroprotection in a rat model of aluminum‐induced dementia

Background Alzheimer's disease (AD) is a worldwide severe medical and social burden. Liraglutide (LIR) has neuroprotective effects in preclinical animal models. Aim: To explore the probable neuroprotective impact of Glucagon‐like peptide‐1 (GLP‐1) on rats' behavior and to elucidate its und...

Descripción completa

Detalles Bibliográficos
Autores principales: Abd el‐Rady, Nessren M., Ahmed, Amel, Abdel‐Rady, Marwa Mahmoud, Ismail, Omnia I.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7757676/
https://www.ncbi.nlm.nih.gov/pubmed/33355990
http://dx.doi.org/10.14814/phy2.14651

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7757676/
https://www.ncbi.nlm.nih.gov/pubmed/33355990
http://dx.doi.org/10.14814/phy2.14651

Ejemplares similares